| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.6M | -18.9% |
| Cost of Revenue | $14.4M | -5.7% |
| Gross Profit | $251K | -91.0% |
| R&D Expense | $1.4M | -4.7% |
| SG&A Expense | $5.7M | +16.6% |
| Operating Income | -$9.5M | -21.7% |
| Pre-tax Income | -$10.4M | -18.3% |
| Income Tax | -$39K | +81.2% |
| Net Income | -$10.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $2.4M | -24.4% |
| Inventory | $5.5M | +5.2% |
| Current Assets | $20.6M | -6.6% |
| Total Assets | $32.4M | -9.9% |
| Current Liabilities | $4.9M | -34.6% |
| Total Liabilities | $15.8M | -15.6% |
| Stockholders' Equity | $16.7M | -3.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.5M | -80.1% |
| Capital Expenditures | $1.4M | -52.7% |
| Investing Cash Flow | -$424K | +85.3% |
| Financing Cash Flow | $8.5M | +1362.7% |
| Free Cash Flow | -$8.9M | -25.8% |
| -20.7% |
| EPS (Basic) | -$1.64 | -8.6% |